Company Technologies Markets Collaborations Investors Careers Contact Search Antibody Discovery mAbLogix™ is our proprietary cell-based platform that derives human antibodies using a fully in vitro system. This process involves construction of human B-cell libraries, which are then screened against a chosen antigen. Our discovery process is differentiated by the large size of human B-cell libraries generated and by the rapid, cell-based screening process. Together, these capabilities allow us to quickly explore the entire human antibody repertoire and generate fully human monoclonal antibodies (mAbs) against diverse antigens. In conjunction with LEAP® instrumentation, the mAbLogix™ antibody discovery process is shortened and optimized to avoid the limitations of other, animal-derived antibody discovery methods. mAbs have become important in targeting therapeutics against cancer cells, viruses, bacteria and toxins – and also in targeting autoimmune diseases such as diabetes, lupus, rheumatoid arthritis and multiple sclerosis. Technologies UltraVector® RheoSwitch® Cell Systems Informatics Protein Engineering AttSite™ Recombinases LEAP® Antibody Discovery Neurospora & Agaricus Platforms Endometrial Regenerative Cells ActoBiotics® Porcine Research Models BeyondBio™ Scientific Literature Peer Reviewed Publications Posters and Articles Company Synthetic Biology Our Platform Operating Units & Divisions Subsidiaries Management Board of Directors Our Commitment Technologies UltraVector® RheoSwitch® Cell Systems Informatics Protein Engineering AttSite™ Recombinases LEAP® Antibody Discovery Neurospora & Agaricus Platforms Endometrial Regenerative Cells ActoBiotics® Porcine Research Models BeyondBio™ Scientific Literature Markets Health Food Energy Environment Consumer Collaborations Exclusive Channel Collaborations Joint Ventures Private Companies Intrexon Institute for Biomolecular Research Partnering Opportunities Investors Overview Press Releases Collaborator News Stock Information Corporate Governance SEC Filings Events/Conferences Investors Packet FAQ Information Request IRS Form 8937 Careers Contact Legal Notices © 2017 Intrexon